Skip to content

Jwaraghna Effect Of Laghu Sudarshan Churna Vati In Childrens of Navajwara.

A RANDOMIZED CONTROL CLINICAL TRIAL TO STUDY THE JWARAGHNA EFFECT OF LAGHU SUDARSHAN CHURNA VATI IN THE TREATMENT OF NAVAJWARA (FEVER) IN CHILDREN OF AGE 6-15 YEARS - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105827
Enrollment
30
Registered
2026-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R509- Fever, unspecified

Interventions

None listed

Sponsors

DR ARTI SHRIRAM KAVLE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 6 and 15 years 2. Diagnosed with Navajwara (7 days) 3. Oral temperature upto 102.0 F

Exclusion criteria

Exclusion criteria: 1.Fever lasting more than 7 days. 2.Presence of complicated fever, e.g. febrile seizures, altered sensorium. 3.Known hypersensitivity to Laghu Sudarshana Churna vati ingredients. 4. Children with chronic systemic illnesses: Chronic disorders like tuberculosis, cancerous condition, CHD, CKD, HIV etc. 5. Children on immunosuppressants or steroids.

Design outcomes

Primary

MeasureTime frame
To study the jwaraghna effect of Laghu Sdarshan Churna Vati in the treatment of navajwara in children of age 6-15 yearsTimepoint: 24 Hours

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR ASHWINI A PATIL

Goverment Ayurved College and Hospital, Nanded

artikavle1610@gmail.com9373271446

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026